Covid 19 Statement
Abstract Submissions

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 21.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 21.75 Contact Hours.

This education activity will be submitted to the American Association of Nurse Practitioners for approval of up to 4.5 contact hours of accredited education.

CAR T Pre-Conference Workshop
To earn an additional 4.5 AMA PRA Category 1 Credits™, attend the CAR T Preconference Workshop.

Acknowledgement of Commercial Support

This activity is supported by educational grants from  Astellas; AstraZeneca; Daiichi Sankyo, Inc.; Genentech, Inc.; Genmab US, Inc; Jazz Pharmaceuticals, Inc.; Legend Biotech USA, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Seagen Inc. (formally Seattle Genetics, Inc.); Syndax Pharmaceuticals, Inc.; and Takeda Oncology.

25th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

25th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

Virtual, Interactive Conference
February 25, 2021 – February 28, 2021

February 25, 2021 - 12:30 PM - 6:10 PM ET
February 26, 2021 - 6:00 AM - 6:30 PM ET
February 27, 2021 - 6:00 AM - 6:30 PM ET
February 28, 2021 - 6:15 AM - 1:35 PM ET


Now in its 25th year, the annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma provides practitioners who manage hematologic malignancies with the practical tools to translate emerging data into the best therapy for their patients, to personalize care according to patient and tumor characteristics, and to apply novel treatment strategies to improve patient outcomes.

We are pleased to continue expanded coverage on chimeric antigen receptor (CAR) T cells and other immune-based therapies in 2021. First, a full afternoon session on Thursday, February 25, 2021, will be dedicated to addressing advances in CAR T-cell therapy for hematologic malignancies, as well as other immune-based therapies and strategies to overcome treatment resistance. Next, sessions on Friday, Saturday, and Sunday will focus on methods to apply state-of-the-art treatment strategies in your clinical practice setting. This engaging and highly interactive meeting will provide ample opportunity for attendees to interact with internationally renowned experts in the management of leukemias, lymphomas, myeloma, myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPNs), and benign hematologic malignancies. Our faculty will distill practice-changing evidence and recommend how to put this information into clinical context, so that you may apply the latest evidence to real-world patient-care scenarios. Proactive measures to mitigate and manage treatment-related toxicities associated with new cellular therapies will also be discussed. Finally, we will continue to provide expert opinion on how the value-based landscape will impact your clinical practice.

Interspersed throughout the meeting are sessions of Medical Crossfire®, a nationally recognized healthcare communication platform for debate, discussion, and peer exchange. These sessions will provide attendees with the opportunity to explore some of the most challenging clinical situations in the management of hematologic malignancies—treatment scenarios with multiple potential approaches.

This dynamic congress will inspire participants to reflect on and share the new information they have learned, and to apply these new practices in the clinical setting, with the ultimate goal of improving patient outcomes.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Astellas; AstraZeneca; Daiichi Sankyo, Inc.; Genentech, Inc.; Genmab US, Inc; Jazz Pharmaceuticals, Inc.; Legend Biotech USA, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Seagen Inc. (formally Seattle Genetics, Inc.); Syndax Pharmaceuticals, Inc.; and Takeda Oncology.

Benefits of Attending

  • Keep up-to-date with emerging and recently approved agents and approaches for patients with hematologic malignancies and benign hematologic disorders
  • Learn about how molecular profiling and other emerging techniques for risk assessment can help optimize therapy for your patients
  • Elevate your competence in managing treatment-related adverse events
  • Network with your peers and internationally renowned experts in hematology/oncology

Hot Topics

  • How to apply newly approved agents in hematologic malignancies
  • The latest developments in CAR T-cell therapy
  • The increasing importance of genomics and molecular testing in hematologic malignancies
  • How to cope with the emerging value-based care landscape

Target Audience

This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.

Program Co-Chairs

Andre H. Goy, MD
Andre H. Goy, MD
Physician in Chief Hackensack Meridian Health Oncology Care Transformation Service
Chairman & Chief Physician Officer - John Theurer Cancer Center
Lydia Pfund Chair for Lymphoma
Academic Chairman Oncology- Hackensack Meridian School of Medicine at Seton Hall University
Professor of Medicine – Georgetown University
Hackensack, NJ
Jorge E. Cortes, MD
Jorge E. Cortes, MD
Director, Georgia Cancer Center
Eminent Scholar, Georgia Research Alliance
Augusta University
Augusta, GA
Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP
Professor and Chair, Department of Hematology & Medical Oncology
Emory School of Medicine
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, GA


3 Ways to Register

  1. Online: Click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701 (credit cards only).
  3. Fax: (609) 257-0705 (credit cards only).

Physicians' Education Resource - HEM21

2 Clarke Drive
Suite 100
Cranbury, NJ 08512
Registration Fees
  Advanced Webcast Week of Virtual
Physicians $99 $149
Fellows* $69 $99
Nurses, PAs, Other Health Care Professionals $49 $79
Industry** $499 $599

*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email info@gotoper.com, or call +1-(888)-949-0045 or +1-(609)-378-3701.

A cancellation fee of 25% will be assessed on refunds requested prior to January 9, 2021, and a 50% fee on refunds requested from January 10, 2021, through February 7, 2021. No refunds will be made after February 8, 2021. There is no charge for substitution. Substitutions can only be applied to the same conference, and only 2 substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

Meeting information is accurate at the time of posting.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By